Doglabs

Doglabs is a biotechnology and healthcare startup founded in 2020 and headquartered in Portugal. The company focuses on canine biodetection for virus and disease identification, including deploying SARS-CoV-2 detection K9 units. Doglabs, formerly known as Howl One, has developed innovative biodetection solutions that can identify viruses, bacteria, and diagnose diseases. Their approach allows for multiple diagnoses with just one test, and individuals can even conduct the tests in their own homes.

Currently, Doglabs is committed to enhancing canine operations and is working towards deploying specialized SARS-CoV-2 and cancer biodetection K9 units globally. Despite the lack of specific information about their last investment, Doglabs' innovative approach to disease detection and their focus on the application of canine biodetection technology in combating global health challenges make them an intriguing prospect for potential investors in the biotechnology and healthcare sectors.